| Date | Time | Source | Headline | Symbol | Company |
| 04/28/2016 | 7:03AM | Business Wire | Sucampo Standardizes on Veeva Vault for a Single Source of Truth Enterprise-wide | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 04/20/2016 | 6:45AM | GlobeNewswire Inc. | Sucampo Announces First Quarter 2016 Earnings Call | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 04/19/2016 | 7:00AM | GlobeNewswire Inc. | Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone in Patients with PPI-Refractory Non-Erosive Reflux Disease ... | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 04/18/2016 | 5:02PM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 03/09/2016 | 7:46PM | GlobeNewswire Inc. | Sucampo Reports Continued Strong Performance for Fourth Quarter and Full Year 2015 | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 03/09/2016 | 6:45AM | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 28th Annual ROTH Conference | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 03/08/2016 | 6:36AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 03/04/2016 | 6:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 03/04/2016 | 6:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 03/04/2016 | 6:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 03/04/2016 | 5:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 03/04/2016 | 5:50PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 03/04/2016 | 5:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 02/16/2016 | 6:04PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 02/16/2016 | 6:03PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 02/16/2016 | 6:02PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 02/11/2016 | 6:46AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 02/04/2016 | 6:30AM | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 Leerink Global Healthcare Conference | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 01/28/2016 | 4:02PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 01/14/2016 | 4:40PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 01/11/2016 | 6:56AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 01/11/2016 | 6:45AM | GlobeNewswire Inc. | Sucampo Enters Into Exclusive Option and Collaboration Agreement With Cancer Prevention Pharmaceuticals for Development of La... | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 01/07/2016 | 7:06AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 01/07/2016 | 7:00AM | GlobeNewswire Inc. | Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 01/05/2016 | 4:47PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 12/15/2015 | 4:19PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 12/15/2015 | 4:15PM | GlobeNewswire Inc. | Sucampo CEO Peter Greenleaf Appointed Chairman of the Board of Directors | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 12/07/2015 | 6:45AM | GlobeNewswire Inc. | Sucampo Completes Acquisition of R-Tech Ueno | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 12/02/2015 | 6:46AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
| 11/25/2015 | 6:30AM | GlobeNewswire Inc. | Sucampo Announces Webcast of Its Presentation at Piper Jaffray 27th Annual Healthcare Conference | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |